Abstract
Background458 patients with rheumatoid arthritis (RA) and unsatisfactory response to DMARDs alone and/or TNFα blocking agents were treated with the IL-1 receptor antagonist anakinra. The initial analysis showed no difference...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have